Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.

Source:http://linkedlifedata.com/resource/pubmed/id/18628471

Clin. Cancer Res. 2008 Jul 15 14 14 4556-63

Download in:

View as

General Info

PMID
18628471